ALK-Positive
Advertisement
Treating Metastatic Non-Small Cell Lung Cancer With Driver Mutations
The Fellow on CallThe Fellow on Call | September 22, 2023
What's the best approach for treating metastatic non-small cell lung cancers that possess certain mutations?
Listen Now
First-Line Lorlatinib Improves Survival and Metastasis in Advanced ALK-Positive Lung Cancer
Rebecca AraujoNon-Small Cell Lung Cancer | September 21, 2023
Early treatment with the anaplastic lymphoma kinase (ALK)-inhibitor lorlatinib reduced cancer progression and death in ...
Read More
FDA Approves New Treatment for ALK-Positive Metastatic NSCLC
Kerri FitzgeraldNon-Small Cell Lung Cancer | September 19, 2023
The U.S. Food and Drug Administration approved lorlatinib for patients with ALK-positive metastatic non-small cell ...
Read More
Advertisement
Advertisement
Advertisement
Latest News

New Findings in Breast Cell Chromosomes May Challenge Early Disease Detection, Benefit Other Organ Disease Detection

December 3, 2024

Assessing the Relationship Between Cardiac Implantable Electronic Devices, Tricuspid Regurgitation

December 3, 2024

Tumor Treating Fields With Gemcitabine, Nab-Paclitaxel Improve OS in Advanced Pancreatic Cancer

December 3, 2024

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Contribute

    Contact Us

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy